Af­ter cash fun­nel­ing scan­dal, biotech bil­lion­aire Soon-Sh­iong charges on with Nant IPO

Patrick Soon-Sh­iong, the biotech bil­lion­aire em­broiled in scan­dal last year, is cor­ralling bankers for a new IPO he’s plan­ning to fund an ex­per­i­men­tal can­cer drug com­pa­ny.

Soon-Sh­iong is the founder of Cul­ver City, Cal­i­for­nia-based Nant­works, from which he spun off two pub­licly-trad­ed com­pa­nies: NantHealth and Nan­tK­west. The new­ly-formed ven­ture will sim­ply be called Nant, the lat­est com­pa­ny to take on the lega­cy name.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER